417 related articles for article (PubMed ID: 24400600)
1. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
Snider GW; Dustin CM; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
[TBL] [Abstract][Full Text] [Related]
2. Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium?
Lothrop AP; Snider GW; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):554-65. PubMed ID: 24393022
[TBL] [Abstract][Full Text] [Related]
3. Selenium as an electron acceptor during the catalytic mechanism of thioredoxin reductase.
Lothrop AP; Snider GW; Ruggles EL; Patel AS; Lees WJ; Hondal RJ
Biochemistry; 2014 Feb; 53(4):654-63. PubMed ID: 24422500
[TBL] [Abstract][Full Text] [Related]
4. No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue.
Lothrop AP; Ruggles EL; Hondal RJ
Biochemistry; 2009 Jul; 48(26):6213-23. PubMed ID: 19366212
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster.
Bauer H; Massey V; Arscott LD; Schirmer RH; Ballou DP; Williams CH
J Biol Chem; 2003 Aug; 278(35):33020-8. PubMed ID: 12816954
[TBL] [Abstract][Full Text] [Related]
6. A "Seleno Effect" Differentiates the Roles of Redox Active Cysteine Residues in Plasmodium falciparum Thioredoxin Reductase.
O'Keefe JP; Dustin CM; Barber D; Snider GW; Hondal RJ
Biochemistry; 2018 Mar; 57(11):1767-1778. PubMed ID: 29485860
[TBL] [Abstract][Full Text] [Related]
7. Compensating for the absence of selenocysteine in high-molecular weight thioredoxin reductases: the electrophilic activation hypothesis.
Lothrop AP; Snider GW; Flemer S; Ruggles EL; Davidson RS; Lamb AL; Hondal RJ
Biochemistry; 2014 Feb; 53(4):664-74. PubMed ID: 24490974
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the C-terminal redox center of high-Mr thioredoxin reductase by protein engineering and semisynthesis.
Eckenroth BE; Lacey BM; Lothrop AP; Harris KM; Hondal RJ
Biochemistry; 2007 Aug; 46(33):9472-83. PubMed ID: 17661444
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
10. Selenium in thioredoxin reductase: a mechanistic perspective.
Lacey BM; Eckenroth BE; Flemer S; Hondal RJ
Biochemistry; 2008 Dec; 47(48):12810-21. PubMed ID: 18986163
[TBL] [Abstract][Full Text] [Related]
11. Methaneseleninic acid is a substrate for truncated mammalian thioredoxin reductase: implications for the catalytic mechanism and redox signaling.
Snider G; Grout L; Ruggles EL; Hondal RJ
Biochemistry; 2010 Dec; 49(48):10329-38. PubMed ID: 21038895
[TBL] [Abstract][Full Text] [Related]
12. Identification and conformer analysis of a novel redox-active motif, Pro-Ala-Ser-Cys-Cys-Ser, in Drosophila thioredoxin reductase by semiempirical molecular orbital calculation.
Kuwahara M; Tamura T; Kawamura K; Inagaki K
Biosci Biotechnol Biochem; 2011; 75(3):516-21. PubMed ID: 21389620
[TBL] [Abstract][Full Text] [Related]
13. Gain of function conferred by selenocysteine: catalytic enhancement of one-electron transfer reactions by thioredoxin reductase.
Barber DR; Hondal RJ
Protein Sci; 2019 Jan; 28(1):79-89. PubMed ID: 30052295
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical studies reveal differences in the catalytic mechanisms of mammalian and Drosophila melanogaster thioredoxin reductases.
Eckenroth BE; Rould MA; Hondal RJ; Everse SJ
Biochemistry; 2007 Apr; 46(16):4694-705. PubMed ID: 17385893
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme.
Sandalova T; Zhong L; Lindqvist Y; Holmgren A; Schneider G
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9533-8. PubMed ID: 11481439
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol.
Wang PF; Arscott LD; Gilberger TW; Müller S; Williams CH
Biochemistry; 1999 Mar; 38(10):3187-96. PubMed ID: 10074374
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of wild type and SeCys/Cys mutant of human thioredoxin reductase in E. coli: the role of selenocysteine in the catalytic activity.
Bar-Noy S; Gorlatov SN; Stadtman TC
Free Radic Biol Med; 2001 Jan; 30(1):51-61. PubMed ID: 11134895
[TBL] [Abstract][Full Text] [Related]
19. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase.
Fujiwara N; Fujii T; Fujii J; Taniguchi N
J Biochem; 2001 May; 129(5):803-12. PubMed ID: 11328605
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of peptide substrates for mammalian thioredoxin reductase.
Flemer S; Lacey BM; Hondal RJ
J Pept Sci; 2008 May; 14(5):637-47. PubMed ID: 18035847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
